Related Experiment Videos
Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes
L Dölken1, F Schüler, G Dölken
1Klinik und Poliklinik für Innere Medizin C, Ernst-Moritz-Arndt-Universität, Greifswald, Germany.
Biotechniques
|December 24, 1998
Summary
We developed a real-time quantitative PCR assay to detect t(14;18)-positive cells in lymphoma patients. This method offers a sensitive and reproducible way to identify minimal residual disease.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The t(14;18) translocation is a hallmark of follicular lymphoma.
- Accurate detection of t(14;18)-positive cells is crucial for molecular staging and monitoring minimal residual disease.
Purpose of the Study:
- To establish an automated, real-time quantitative PCR assay for detecting t(14;18)-positive cells.
- To evaluate the sensitivity, reproducibility, and advantages of this new assay compared to conventional methods.
Main Methods:
- Development of a real-time quantitative PCR assay using double-labeled fluorogenic probes.
- Validation using known copy numbers of t(14;18)-positive genomic DNA.
- Analysis of peripheral blood mononuclear cells (PBMNC) from follicular lymphoma patients using both real-time PCR and a two-step semi-nested PCR with limiting dilution.
Main Results:
- The real-time PCR assay demonstrated high reproducibility for initial copy numbers ranging from 10 to 10(5).
- Single-copy detection was confirmed using a stochastic multiple-tube approach.
- Quantitative results from real-time PCR correlated well with those from the two-step PCR method.
- The assay offers advantages including fewer critical pipetting steps, reduced time, and built-in contamination control.
Conclusions:
- Real-time quantitative PCR provides a sensitive, specific, and reproducible method for detecting t(14;18)-positive cells.
- This assay is valuable for molecular staging, detecting minimal residual tumor cells, and epidemiological studies.
- It is particularly useful for analyzing blood stem-cell preparations for transplantation.